Genomic Characterization of Acral Melanoma
Demographics (2)
- AGE - Age at biopsy (phv00258917.v1.p1)
- SEX - Gender of participant (phv00258918.v1.p1)
Disease Events (3)
- BODY_SITE - Body site where sample was collected (phv00258921.v1.p1)
- IS_TUMOR - Is the sample tumor (phv00258923.v1.p1)
- STAGE_PRESENTATION - Stage at presentation (phv00258925.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00258919.v1.p1)
Other (10)
- ANALYTE_TYPE - Analyte Type (phv00258922.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00258912.v1.p1)
- PRIMARY_MET - Is this the primary tumor or the metastasis (phv00258924.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00258920.v1.p1)
- SAMPLE_ID - Sample ID (phv00258914.v1.p1)
- SAMPLE_USE - Sample use. Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_WholeExome: Whole exome sequencing; Seq_DNA_WholeGenome: Whole genome sequencing; Seq_RNA: Whole transcriptome sequencing (phv00258915.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00258926.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00258916.v1.p1)
- SUBJECT_ID - Subject ID (phv00258913.v1.p1)
- SUBJECT_ID - Subject ID (phv00258911.v1.p1)